Rapid Communication
Copyright ©2008 The WJG Press and Baishideng.
World J Gastroenterol. Apr 14, 2008; 14(14): 2262-2267
Published online Apr 14, 2008. doi: 10.3748/wjg.14.2262
Table 1 Characteristics of patients with GVHD
Case No./Sex/AgeDiagnosisConditioning regimensDonor HLA matchGVHD prophylaxisStage grading
1/F/29AML-M2BU/CYHLA 2-locus mismatched unrelated donorCSA, ATG, MMFMTXaGVHD grade IV
2/M/47CML-CRFludarabine, Bu, ATGHLA-identical sibling donorCSA, MTXcGVHD Limited
3/M/39CML -CRBU/CYHLA-identical sibling donorCSA, MTXcGVHD/Limited
4/M/23CML-CRBU/CYHLA-identical sibling donorCSA, MTXaGVHD grade IV
5/M/63CML-CRFludarabine, Bu, ATGHLA-identical sibling donorCSA, MTXaGVHD grade IV
6/F/35ALL-CRMe-CCNU, TBI, Ara-C, CYHLA 2-locus mismatched related donorCSA, MTX, MMF, ATGaGVHD grade IV
7/M/42ALL-CRBU/CY, Me-CCNU, Ara-CHLA 2-locus mismatched related donorCSA, MTX, MMF, ATGaGVHD grade III
8/F/23ALL-CRMe-CCNU, TBI, Ara-C, CYHLA 2-locus mismatched related donorCSA, MTX, MMF, ATG Anti-CD25aGVHD grade III